AGP Picks
View all

Wasteless Bio and BADASS Labs team up to cut biotech lab costs and waste

Aug. 4, 2026
By AI, Created 20:54 UTC, Aug 04, 2026, AGP -

Wasteless Bio and BADASS Labs announced a strategic partnership on August 4, 2026, to help early-stage biotech companies buy and resell lab equipment at lower cost. The deal is designed to stretch startup runway while reducing surplus waste and Scope 3 emissions through reuse.

Why it matters: - Early-stage biotech companies often burn cash on procurement and lab equipment before they reach the next funding milestone. - The partnership aims to lower those costs and keep usable equipment out of landfill. - The reuse model also targets Scope 3 emissions tied to manufacturing new lab gear.

What happened: - Wasteless Bio and BADASS Labs announced a strategic partnership on August 4, 2026. - The collaboration connects BADASS Labs’ Mission Booster Procurement service with Wasteless Bio’s circular marketplace. - BADASS Labs is a nonprofit biotech incubator based in Alameda, California. - Wasteless Bio is an online marketplace for surplus life-science equipment, consumables, and reagents.

The details: - BADASS Labs members and Mission Booster Procurement clients get access to Wasteless Bio listings of surplus, unused, and second-hand lab instruments, consumables, and reagents. - Those items are often available at a substantial discount to list price. - Founders with surplus equipment can list assets on Wasteless Bio to recover capital from idle inventory. - The partnership is meant to reduce both procurement costs and waste. - Wasteless Bio says labs can source vetted equipment, consumables, and reagents at 50% to 90% below new prices while avoiding OEM back orders. - Wasteless Bio also says organizations can resell or redistribute surplus assets to keep resources in circulation. - BADASS Labs has supported dozens of biotech ventures since opening in 2020. - BADASS Labs says its client companies have collectively raised more than $900 million. - Wasteless Bio was founded in 2024 and now operates in the United Kingdom, Europe, and the United States. - Wasteless Bio serves researchers, universities, and life-science organizations seeking affordable equipment and surplus management options.

Between the lines: - The partnership is built around a rare overlap: sustainability and startup economics point in the same direction. - For biotech founders, extending runway by cutting equipment costs can be as important as raising more capital. - Reuse is one of the few practical ways for labs to lower environmental impact without changing core research activity.

What's next: - Biotech founders, lab managers, and life-science organizations can learn more at wasteless.bio and badasslabs.org. - The companies are positioning the partnership as an ongoing sourcing and resale channel for the biotech ecosystem.

The bottom line: - The deal gives biotech startups a cheaper way to equip labs and a cleaner way to move surplus inventory, while helping both companies push circular procurement in life sciences.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.